Cargando…
The mouse in preclinical trials: transgenic, carcinogen-induced, or xenograph models – which to use?
Autor principal: | Brown, P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300147/ http://dx.doi.org/10.1186/bcr686 |
Ejemplares similares
-
Accelerated sonothrombolysis with Definity in a xenographic porcine cerebral thromboembolism model
por: Kleven, Robert T., et al.
Publicado: (2021) -
Reversibility and progression in conditional transgenic mouse models of breast cancer
por: Chodosh, LA, et al.
Publicado: (2003) -
Expression of aquaporins in a transgenic mouse model of Alzheimer's disease
por: Chan, Sic L, et al.
Publicado: (2010) -
Integrin-mediated signal transduction in transgenic mouse models of human breast cancer
por: White, DE, et al.
Publicado: (2003) -
Herceptin-sensitivity of HER2-transgenic mouse mammary tumors
por: Schwall, RH, et al.
Publicado: (2003)